Advarra is a brand that advances clinical research and enables the development of life-changing therapies. With a focus on safety, compliance, and efficiency, Advarra offers a wide range of products and services to support the research ecosystem. Their services include institutional review board (IRB) and institutional biosafety committee (IBC) review, data monitoring committee (DMC), and endpoint adjudication (EAC) services.

They also provide consulting offerings for quality, regulatory, and clinical research, as well as training services for research professionals. Advarra aims to safeguard trial participants by ensuring protocols are safe and feasible. They empower clinical sites by providing site-centric technologies for optimized collaboration and workflow management.

In addition, they offer innovative regulatory compliance solutions and expertise throughout the research lifecycle. With a data-driven approach and expertise in trial design, Advarra optimizes research performance and fosters collaboration across the clinical ecosystem. With a commitment to diversity, equity, and inclusion, Advarra strives to create an inclusive work environment where all employees feel valued and respected.

They also address underrepresented populations in clinical trials through their products and services, seeking to increase participation and promote equity. Headquartered in Columbia, Maryland, Advarra serves clients globally and has a strong presence in the research and regulatory environment. With over 35 years of experience, Advarra is dedicated to advancing human health and making a positive impact on the world.

Their core values of being patient-centric, ethical, collaborative, and quality-focused drive their mission to accelerate the development of life-changing therapies